Ryan Specialty (NYSE:RYAN) Given New $35.00 Price Target at Piper Sandler

Posted by Brian Himes on May 2nd, 2026

Ryan Specialty (NYSE:RYAN – Free Report) had its price objective reduced by Piper Sandler from $43.00 to $35.00 in a research note published on Friday morning,Benzinga reports. They currently have a neutral rating on the stock.

Several other brokerages have also recently issued reports on RYAN. Zacks Research cut Ryan Specialty from a “hold” rating to a “strong sell” rating in a research note on Tuesday, February 24th. Mizuho set a $35.00 price target on shares of Ryan Specialty in a report on Friday. Weiss Ratings lowered shares of Ryan Specialty from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Thursday, February 5th. UBS Group set a $35.00 price objective on shares of Ryan Specialty in a research note on Friday. Finally, Royal Bank Of Canada assumed coverage on shares of Ryan Specialty in a report on Tuesday, March 17th. They issued an “outperform” rating and a $45.00 price objective on the stock. One investment analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating, six have given a Hold rating and three have given a Sell rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $47.47.

Read Our Latest Stock Analysis on RYAN

Ryan Specialty Stock Performance

Shares of NYSE RYAN traded down $3.89 during mid-day trading on Friday, hitting $30.89. The stock had a trading volume of 5,971,982 shares, compared to its average volume of 1,920,499. The firm has a market cap of $8.16 billion, a PE ratio of 73.54, a PEG ratio of 0.94 and a beta of 0.68. The company has a debt-to-equity ratio of 2.62, a quick ratio of 0.98 and a current ratio of 0.98. The company has a 50 day moving average of $36.08 and a two-hundred day moving average of $46.46. Ryan Specialty has a twelve month low of $29.91 and a twelve month high of $72.50.

Ryan Specialty (NYSE:RYAN – Get Free Report) last issued its quarterly earnings results on Thursday, April 30th. The company reported $0.47 EPS for the quarter, topping analysts’ consensus estimates of $0.43 by $0.04. The company had revenue of $795.23 million during the quarter, compared to analysts’ expectations of $781.44 million. Ryan Specialty had a return on equity of 41.30% and a net margin of 8.21%.The firm’s revenue was up 15.2% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.39 EPS. Research analysts predict that Ryan Specialty will post 2.24 EPS for the current fiscal year.

Ryan Specialty Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, May 26th. Investors of record on Tuesday, May 12th will be given a dividend of $0.13 per share. This represents a $0.52 annualized dividend and a yield of 1.7%. The ex-dividend date is Tuesday, May 12th. Ryan Specialty’s dividend payout ratio (DPR) is currently 123.81%.

Insider Transactions at Ryan Specialty

In related news, Director Patrick G. Ryan, Jr. purchased 25,500 shares of the firm’s stock in a transaction on Monday, February 23rd. The stock was bought at an average cost of $39.96 per share, with a total value of $1,018,980.00. Following the completion of the acquisition, the director owned 428,295 shares of the company’s stock, valued at $17,114,668.20. The trade was a 6.33% increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders own 52.03% of the company’s stock.

Hedge Funds Weigh In On Ryan Specialty

Several large investors have recently made changes to their positions in the company. Fifth Third Bancorp lifted its stake in shares of Ryan Specialty by 4,844.4% in the 1st quarter. Fifth Third Bancorp now owns 32,089 shares of the company’s stock valued at $1,083,000 after purchasing an additional 31,440 shares during the period. Torray Investment Partners LLC grew its position in Ryan Specialty by 12.7% during the first quarter. Torray Investment Partners LLC now owns 68,046 shares of the company’s stock valued at $2,296,000 after buying an additional 7,662 shares during the period. Equitable Trust Co. increased its holdings in Ryan Specialty by 42.8% in the first quarter. Equitable Trust Co. now owns 113,579 shares of the company’s stock valued at $3,832,000 after buying an additional 34,016 shares in the last quarter. Oregon Public Employees Retirement Fund increased its holdings in Ryan Specialty by 3.5% in the first quarter. Oregon Public Employees Retirement Fund now owns 23,417 shares of the company’s stock valued at $790,000 after buying an additional 800 shares in the last quarter. Finally, KERR FINANCIAL PLANNING Corp raised its position in shares of Ryan Specialty by 83.7% in the first quarter. KERR FINANCIAL PLANNING Corp now owns 2,203 shares of the company’s stock worth $77,000 after acquiring an additional 1,004 shares during the period. 84.82% of the stock is currently owned by institutional investors and hedge funds.

Ryan Specialty News Roundup

Here are the key news stories impacting Ryan Specialty this week:

Positive Sentiment: Q1 results beat expectations — EPS $0.47 vs. $0.43 est.; revenue $795.2M, +15.2% YoY and above consensus. Management reported 11.8% organic revenue growth and strong profitability metrics (ROE ~46%). This provides fundamental backing for the business after the quarter. Business Wire: Q1 Results
Positive Sentiment: Keefe, Bruyette & Woods kept an “outperform” rating while lowering its price target to $42 (still implies sizable upside vs. current levels), offering some analyst support for the stock. Benzinga: KBW PT
Positive Sentiment: Board announced a quarterly dividend of $0.13/share (ex-div May 12; pay May 26), an annualized yield ~1.7% — modest income support for shareholders.
Neutral Sentiment: Earnings call transcript and additional coverage are available for detailed readouts of management commentary on growth drivers and expense trends — useful for assessing forward guidance and margin drivers. Seeking Alpha: Q1 Call Transcript
Neutral Sentiment: Multiple outlets (Zacks, Yahoo, MSN) ran summaries noting the beat and key metrics; these amplify visibility but add little new information beyond the press release and call. Zacks: Earnings Coverage
Negative Sentiment: Piper Sandler cut its price target from $43 to $35 and moved to “neutral” — this reduces some analyst-implied upside and likely pressured sentiment. Benzinga: Piper Sandler PT Cut
Negative Sentiment: Wells Fargo reaffirmed an “equal weight” stance but slashed its target from $42 to $31, leaving little upside relative to the current price and adding downside risk. Benzinga: Wells Fargo PT Cut

Ryan Specialty Company Profile

(Get Free Report)

Ryan Specialty Group, Inc (NYSE: RYAN) is a global specialty insurance and reinsurance platform that partners with a network of insurers and reinsurers to deliver tailored risk solutions. The company focuses on complex and large-scale risks across multiple industry sectors, leveraging its underwriting expertise to structure coverage programs that meet clients’ unique needs.

Ryan Specialty’s core offerings span a diverse range of specialty lines, including casualty, property, professional liability, marine and energy, program administration, and sports and entertainment.